# Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video)

- Link: https://www.directorstalkinterviews.com/cizzle-biotechnology-new-nhs-aligned-partnership-moves-lung-cancer-test-closer-to-uk-clinics-video/4121224595
- Published: 2025-11-06T07:15:00+00:00
- Author: Ethan Davis

**Cizzle Biotechnology** (LON:CIZ) has taken a critical step toward getting its 
early lung cancer blood test into UK hospitals, signing a letter of intent with 
a major diagnostics partner working alongside the NHS. In this interview, Executive
Chairman Dr Allan Syms outlines how this move supports the NHS’s early detection
strategy, complements their active US licensing model, and accelerates the test’s
return to the UK — where the underlying science was first developed.

### Key Moments

 * **00:12** – LOI signed with NHS-linked diagnostics partner
 * **01:01** – CIZ1B test’s role in global licensing strategy
 * **02:29** – Test’s UK research origins and commercial goal
 * **03:37** – Alignment with NHS early detection ambitions
 * **04:58** – How early diagnosis can reduce cancer fatalities
 * **06:39** – Validation now underway in UK commercial labs
 * **08:03** – US deal comparison and licensing model
 * **09:20** – Pathway to European, Asian, and LATAM markets

**Cizzle Biotechnology** is a UK-based diagnostics developer focused on early-stage
cancer detection through its proprietary CIZ1B blood test.

Share on:
